Physical activity and progression to type 1 diabetes in children and youth with islet autoimmunity: The diabetes autoimmunity study in the young

被引:1
作者
Snell-Bergeon, Janet [1 ,2 ]
Waugh, Kathleen [1 ]
Dong, Fran [1 ]
Steck, Andrea [1 ]
Norris, Jill [2 ]
Rewers, Marian [1 ]
机构
[1] Univ Colorado, Barbara Davis Ctr Diabet, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
accelerometer; autoimmunity; physical activity; type; 1; diabetes; INSULIN-RESISTANCE; ONSET; RISK; AUTOANTIBODIES; ANTIBODIES; CHILDHOOD; ASSAY;
D O I
10.1111/pedi.13323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Hypotheses Physical inactivity may contribute to islet autoimmunity and progression to clinical type 1 diabetes. To test this hypothesis, we evaluated physical activity, assessed by accelerometer, as an independent risk factor for progression to clinical diabetes among genetically at risk for type 1 diabetes children and youth with islet autoimmunity. Methods Accelerometer data were obtained for 95 children and youth participating in the diabetes autoimmunity study in the young who had islet autoimmunity. Islet autoimmunity was defined as the presence of islet autoantibodies to insulin, glutamic acid decarboxylase, tyrosine phosphatase-like protein IA-2, or zinc transporter 8. Results During prospective follow-up for up to 7 years, 13 of the 95 participants progressed to clinical diabetes. In multivariable survival analysis, none of the physical activity parameters examined predicted a higher risk of developing diabetes. In survival analysis with time-varying physical activity parameters, none of the physical activity parameters over time were associated with the risk of developing type 1 diabetes. Conclusions/Interpretation It does not appear that low-physical activity is a risk factor for progression from islet autoantibodies to diabetes in children and youth at high-genetic risk for type 1 diabetes.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 26 条
  • [1] Type 1 diabetes
    Atkinson, Mark A.
    Eisenbarth, George S.
    Michels, Aaron W.
    [J]. LANCET, 2014, 383 (9911) : 69 - 82
  • [2] Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)
    Bingley, Polly J.
    Mahon, Jeffrey L.
    Gale, Edwin A. M.
    [J]. DIABETES CARE, 2008, 31 (01) : 146 - 150
  • [3] Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories
    Bingley, Polly J.
    Williams, Alistair J. K.
    Colman, Peter G.
    Gellert, Shane A.
    Eisenbarth, George
    Yu, Liping
    Perdue, Letitia H.
    Pierce, June J.
    Hilner, Joan E.
    Nierras, Concepcion
    Akolkar, Beena
    Steffes, Michael W.
    [J]. CLINICAL TRIALS, 2010, 7 : S56 - S64
  • [4] Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S34 - S45
  • [5] Validation of Accelerometer Wear and Nonwear Time Classification Algorithm
    Choi, Leena
    Liu, Zhouwen
    Matthews, Charles E.
    Buchowski, Maciej S.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (02) : 357 - 364
  • [6] Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands
    Farsani, Soulmaz Fazeli
    Souverein, Patrick C.
    van der Vorst, Marja M. J.
    Knibbe, Catherijne A. J.
    Herings, Ron M. C.
    de Boer, Anthonius
    Mantel-Teeuwisse, Aukje K.
    [J]. PEDIATRIC DIABETES, 2016, 17 (01) : 44 - 52
  • [7] Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
    Ferrara-Cook, Christine
    Geyer, Susan Michelle
    Evans-Molina, Carmella
    Libman, Ingrid M.
    Becker, Dorothy J.
    Gitelman, Stephen E.
    Redondo, Maria Jose
    [J]. DIABETES CARE, 2020, 43 (03) : 580 - 587
  • [8] Insulin resistance is a risk factor for progression to Type 1 diabetes
    Fourlanos, S
    Narendran, P
    Byrnes, GB
    Colman, PG
    Harrison, LC
    [J]. DIABETOLOGIA, 2004, 47 (10) : 1661 - 1667
  • [9] Calibration of the Computer Science and Applications, Inc. accelerometer
    Freedson, PS
    Melanson, E
    Sirard, J
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1998, 30 (05) : 777 - 781
  • [10] ICA512 AUTOANTIBODY RADIOASSAY
    GIANANI, R
    RABIN, DU
    VERGE, CF
    YU, LP
    BABU, SR
    PIETROPAOLO, M
    EISENBARTH, GS
    [J]. DIABETES, 1995, 44 (11) : 1340 - 1344